| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8297565 | Biochemical and Biophysical Research Communications | 2013 | 7 Pages |
Abstract
These data clearly demonstrate that isonicotinamide exerts anti-diabetogenic effects by preventing β-cell damage after STZ administration. These findings warrant further investigations on the protective effects of isonicotinamide and related compounds against β-cell damage in diabetes.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Makiko Fukaya, Yoshiaki Tamura, Yuko Chiba, Toshihiro Tanioka, Ji Mao, Yoko Inoue, Marina Yamada, Christian Waeber, Yukari Ido-Kitamura, Tadahiro Kitamura, Masao Kaneki,